Abstract:The HIV-1 reservoir is a major obstacle to complete eradication of the virus. Although many proteins and RNAs have been characterized as regulators in HIV-1/AIDS pathogenesis and latency, only a few long noncoding RNAs (lncRNAs) have been shown to be closely associated with HIV-1 replication and latency. In this study, we demonstrated that lncRNA uc002yug.2 plays a key role in HIV-1 replication and latency. uc002yug. 2 potentially enhances HIV-1 replication, long terminal repeat (LTR) activity, and the activation of latent HIV-1 in both cell lines and CD4(+) T cells from patients. Further investigation revealed that uc002yug.2 activates latent HIV-1 through downregulating RUNX1b and -1c and upregulating Tat protein expression. The accumulated evidence supports our model that the Tat protein has the key role in the uc002yug.2-mediated regulatory effect on HIV-1 reactivation. Moreover, uc002yug. 2 showed an ability to activate HIV-1 similar to that of suberoylanilide hydroxamic acid or phorbol 12-myristate 13-acetate using latently infected cell models. These findings improve our understanding of lncRNA regulation of HIV-1 replication and latency, providing new insights into potential targeted therapeutic interventions. IMPORTANCE The latent viral reservoir is the primary obstacle to curing HIV-1 disease. To date, only a few lncRNAs, which play major roles in various biological processes, including viral infection, have been identified as regulators in HIV-1 latency. In this study, we demonstrated that lncRNA uc002yug.2 is important for both HIV-1 replication and activation of latent viruses. Moreover, uc002yug.2 was shown to activate latent HIV-1 through regulating alternative splicing of RUNX1 and increasing the expression of Tat protein. These findings highlight the potential merit of targeting lncRNA uc002yug. 2 as an activating agent for latent HIV-1.

MicroRNAs and long non-coding RNAs during transcriptional regulation and latency of HIV and HTLV

Identify Potential Regulators in Hiv-1 Latency by Joint Microrna and Mrna Analysis

High-throughput Sequencing Identifies HIV-1-replication- and Latency-Related Mirnas in CD4+ T Cell Lines.

Role of long noncoding RNA in regulating HIV infection—a comprehensive review

MicroRNA regulation of viral immunity, latency, and carcinogenesis of selected tumor viruses and HIV

The Role of MicroRNAs in HIV Infection

MicroRNAs and exosomes: key players in HIV pathogenesis

Targeting Viral Transcription for HIV Cure Strategies

Targeting noncoding RNAs to reactivate or eliminate latent HIV reservoirs

MicroRNA Regulation of Human Herpesvirus Latency

Post-Transcriptional HIV-1 Latency: A Promising Target for Therapy?

Transcriptomic study reveals alteration in the expression of long non-coding RNAs (lncRNAs) during reversal of HIV-1 latency in monocytic cell line

Two Cellular Micrornas, Mir-196B and Mir-1290, Contribute to HIV-1 Latency

Human herpesvirus-encoded MicroRNA in host-pathogen interaction

Long non-coding RNA uc002yug.2 activates HIV-1 latency through regulating mRNA level of various RUNX1 isoforms and increasing Tat expression.

Non-coding RNAs and Retroviruses.

Cellular microRNAs contribute to HIV-1 latency in resting primary CD4 + T lymphocytes

Biological function of microRNA in HIV-1 infection:summary of recent progress

miRNAs and human immunodeficiency virus type 1 infection:biomarkers and antiviral therapy

Differential expression of lncRNAs during the HIV replication cycle: an underestimated layer in the HIV-host interplay

Long Noncoding RNA NRON Contributes to HIV-1 Latency by Specifically Inducing Tat Protein Degradation